FDA Issues Final Rule for Over-the-Counter Pain Relievers with New Warnings

Summary

The Food and Drug Administration (FDA) has issued a final rule requiring new organ-specific warnings and labeling for over-the-counter pain relievers, including acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), to inform consumers of potential liver injury and stomach bleeding risks.